Tag Archives: metastatic melanoma

November, 2018

September, 2017

June, 2017

February, 2017

January, 2016

November, 2015

  • 23 November

    Roche’s Melanoma Drug Performs Well in Early-Stage Study

    Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced data from the pivotal coBRIM study, which showed that Cotellic (cobimetinib) in combination with Zelboraf (vemurafenib) helped people with BRAF V600E and V600K mutation-positive unresectable or metastatic melanoma live significantly longer (overall survival; OS) than with Zelboraf alone.1 Cotellic plus Zelboraf reduced …